ChromaDex (CDXC) Misses Q2 EPS by 1c

ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.7 million versus the consensus estimate of $18.68 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Bernstein: 'Case studies from Microchip and other Semiconductor LTAs - What's different this time?'
• Donerail urges Beazer Homes board to engage with DFH's $32 offer